Treatment of Moderate to Severe Glabellar Lines
Public ClinicalTrials.gov record NCT04249583. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of QM1114-DP for the Treatment of Moderate to Severe Glabellar Lines
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of the study is to evaluate the efficacy and safety of a single dose of QM1114-DP compared to placebo for the treatment of moderate to severe GL.
Study identification
- NCT ID
- NCT04249583
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 300 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 10, 2020 (Actual)
- Primary completion
- Aug 7, 2020 (Actual)
- Completion
- Jan 5, 2021 (Actual)
- Last update posted
- Jun 18, 2023
2020 – 2021
United States locations
- U.S. sites
- 13
- U.S. states
- 8
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| \Ablon Skin Institute and Research Center | Manhattan Beach | California | 90266 | — |
| Moradi MD | Vista | California | 92083 | — |
| Etre Cosmetic Dermatology and Laser Center | New Orleans | Louisiana | 70130 | — |
| Maryland Dermatology, Laser Skin & Vein | Hunt Valley | Maryland | 21030 | — |
| Skin Specialist, PC | Omaha | Nebraska | 68144 | — |
| Robert Schwarcz, MD, PC | New York | New York | 10021 | — |
| Sachin M Shridharani, MD | New York | New York | 10021 | — |
| Wilmington Dermatology Center, PLLC | Wilmington | North Carolina | 28405 | — |
| The Practice of Brian S Biesman, MD | Nashville | Tennessee | 37203 | — |
| Tennessee Clinical Research Center | Nashville | Tennessee | 37215 | — |
| Dallas Center for Dermatology & Aesthetics | Dallas | Texas | 75225 | — |
| Austin Institute for Clinical Research, Inc. | Pflugerville | Texas | 78660 | — |
| Integrated Aesthetics, Inc | Spring | Texas | 77388 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04249583, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 18, 2023 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04249583 live on ClinicalTrials.gov.